1. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting st-ents. JAMA. 2005. 293:2126–2130.
2. Blich M, Zeidan-Shwiri T, Petcherski S, Osherov A, Hammerman H. Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice. J Invasive Cardiol. 2010. 22:461–464.
3. Lee AY. Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants. Hematology Am Soc Hematol Educ Program. 2010. 2010:144–149.
4. Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol. 2009. 27:4839–4847.
5. De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004. 50:187–196.
6. Nakagawa T, Yasuno M, Tanahashi H, et al. A case of acute myocardial infarction: intracoronary thrombosis in two major coronary arteries due to hormone therapy. Angiology. 1994. 45:333–338.
7. Canale ML, Camerini A, Stroppa S, et al. A case of acute myocardial infarction during 5-fluorouracil infusion. J Cardiovasc Med (Hagerstown). 2006. 7:835–837.
8. Wijesinghe N, Thompson PI, McAlister H. Acute coronary syndrome induced by capecitabine therapy. Heart Lung Circ. 2006. 15:337–339.
9. Kalapura T, Krishnamurthy M, Reddy CV. Acute myocardial infarction following gemcitabine therapy: a case report. Angiology. 1999. 50:1021–1025.
10. Gemici G, Cinçin A, Değertekin M, Oktay A. Paclitaxel-induced ST-segment elevations. Clin Cardiol. 2009. 32:E94–E96.
11. Lee SP, Suh JW, Park KW, et al. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: a multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease. Trials. 2010. 11:87.
12. Gurbel PA, Bliden KP, Butler K, et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the respond study. Circulation. 2010. 121:1188–1199.
13. Montalescot G, Wiviott SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009. 373:723–731.